Impact of B-type natriuretic peptide (BNP) on development of atrial fibrillation in people with Type 2 diabetes.

about

N-terminal-pro brain natriuretic peptides in dogs and cats: A technical and clinical review.Association of brain natriuretic peptide gene polymorphisms with chronic obstructive pulmonary disease complicated with pulmonary hypertension and its mechanism

P2860

Q46438819-032DAA6B-ABCE-42D4-852F-E25F625DE164 Q57044351-7C9371B6-5E62-4BE9-91AD-82987B9BAE9F

P2860

Impact of B-type natriuretic peptide (BNP) on development of atrial fibrillation in people with Type 2 diabetes.

Item

http://www.wikidata.org/entity/Q38984938

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Impact of B-type natriuretic p ...... n people with Type 2 diabetes.

@en

type

Item

label

Impact of B-type natriuretic p ...... n people with Type 2 diabetes.

@en

prefLabel

Impact of B-type natriuretic p ...... n people with Type 2 diabetes.

@en

P1476

Impact of B-type natriuretic p ...... n people with Type 2 diabetes.

@en

P2093

H Makino

http://www.w3.org/2001/XMLSchema#string

H Ogawa

http://www.w3.org/2001/XMLSchema#string

I Kishimoto

http://www.w3.org/2001/XMLSchema#string

K Kusano

http://www.w3.org/2001/XMLSchema#string

K Minematsu

http://www.w3.org/2001/XMLSchema#string

K Toyoda

http://www.w3.org/2001/XMLSchema#string

M Tochiya

http://www.w3.org/2001/XMLSchema#string

S Yasuda

http://www.w3.org/2001/XMLSchema#string

T Tamanaha

http://www.w3.org/2001/XMLSchema#string

Y Ohata

http://www.w3.org/2001/XMLSchema#string

P2860

Time-dependent ROC curves for censored survival data and a diagnostic marker.

N-terminal pro-B-type natriuretic peptide is a major predictor of the development of atrial fibrillation: the Cardiovascular Health Study.

Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide.

Plasma natriuretic peptide levels and the risk of cardiovascular events and death.

A prospective study in search of an optimal B-natriuretic peptide level to screen patients for cardiac dysfunction.

Assessment of conventional cardiovascular risk factors and multiple biomarkers for the prediction of incident heart failure and atrial fibrillation.

Outcome parameters for trials in atrial fibrillation: recommendations from a consensus conference organized by the German Atrial Fibrillation Competence NETwork and the European Heart Rhythm Association.

Meta-analysis of cohort and case-control studies of type 2 diabetes mellitus and risk of atrial fibrillation.

Relations of biomarkers of distinct pathophysiological pathways and atrial fibrillation incidence in the community.

Value of plasma B type natriuretic peptide measurement for heart disease screening in a Japanese population

P304

1118-1124

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/DME.12856

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Toshihisa Anzai

P577

2015-07-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

280119274

http://www.w3.org/2001/XMLSchema#string

P698

26173591

http://www.w3.org/2001/XMLSchema#string

Impact of B-type natriuretic peptide (BNP) on development of atrial fibrillation in people with Type 2 diabetes.

about

P2860

P2860

Impact of B-type natriuretic peptide (BNP) on development of atrial fibrillation in people with Type 2 diabetes.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698